|
GTSE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.393600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.469600E-01 |
| Normal-vs-Stage2 |
1.274590E-01 |
| Normal-vs-Stage3 |
9.057400E-01 |
| Normal-vs-Stage4 |
7.560800E-01 |
| Stage1-vs-Stage2 |
7.92090000000245E-05 |
| Stage1-vs-Stage3 |
8.959600E-01 |
| Stage1-vs-Stage4 |
4.730600E-01 |
| Stage2-vs-Stage3 |
2.482400E-03 |
| Stage2-vs-Stage4 |
2.401000E-03 |
| Stage3-vs-Stage4 |
4.711800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.366400E-01 |
| Normal-vs-AfricanAmerican |
2.759200E-01 |
| Normal-vs-Asian |
8.820400E-01 |
| Caucasian-vs-AfricanAmerican |
1.902220E-02 |
| Caucasian-vs-Asian |
6.885000E-01 |
| AfricanAmerican-vs-Asian |
1.534410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.953600E-01 |
| Normal-vs-Female |
7.843200E-01 |
| Male-vs-Female |
4.823600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.273200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.174200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.982200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.170770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.977700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.741000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.459800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.976300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.411600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.184810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.743400E-01 |
| Classical-VS-Follicular |
2.03200000004067E-06 |
| Classical-VS-Other |
3.764000E-02 |
| Classical-VS-Normal |
8.669400E-01 |
| Tall-VS-Follicular |
2.155100E-03 |
| Tall-VS-Other |
5.993900E-02 |
| Tall-VS-Normal |
7.491200E-01 |
| Follicular-VS-Other |
7.486600E-01 |
| Follicular-VS-Normal |
1.301200E-01 |
| Other-VS-Normal |
2.733600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.313200E-01 |
| Normal-vs-N1 |
8.211800E-01 |
| N0-vs-N1 |
5.960000E-01 |
|
|
